The immune system is made up of a network of cells, tissues, and organs that work together to protect the body against infectious organisms and other invaders. The immune system has an essential role in various diseases. New techniques and technologies have led to an in-depth understanding of the various immune cells in the context of disease biology.
This understanding has paved the way for the development of novel drugs and diagnostics and an increased investment by pharmaceutical and biotechnology companies in immune-mediated disease research.
With an increased focus on drug prices and the rising research and development costs, the applications of technology, real-world evidence of disease of drug development all for an efficient and cost-effective systems that can aide biopharmaceutical companies in selecting the right drug candidates early in the pre-clinical stage and ensure capital and resources are channeled appropriately towards translational studies and into clinical trials.
We develop, partner or procure platforms, technology solutions and model systems that are synergistic to one another with a common denominator of analyzing human derived cells and cell lines
We aim to bring efficiency and expediency to the drug development process by incorporating research data, real-world patient data and clinical evidence into the selection of cells, assays and platforms. We believe this systematic approach coupled with technology solutions, -omics and instrumentation should lead to meaningful drug development solutions and in turn accelerate drug development